An international association of pharmaceutical, biotechnology, and diagnostics companies today announced the formation of a new alliance to monitor and drive industry efforts to fight antimicrobial resistance (AMR). The AMR Industry Alliance aims to bring together stakeholders from the life sciences industry to ensure progress is made on their commitments to reduce the development of antimicrobial resistance, invest in research and development, and improve global access to antimicrobials, diagnostic tests, and vaccines. Read more….
- Leonie de Best, CBO of Madam Therapeutics, is in Paris to engage in B2B meetings at BioEquity Europe 2017
- CEO Madam Therapeutics interviewed on Dutch Radio Show